Finding The Voices that Matter - How Do We Reach More Patients With CGT?

Chair

Tom Whitehead, Founder, Emily Whitehead Foundation

4pm Presentation

Yael Weiss, Chief Executive Officer, Mahzi Therapeutics

4.15pm Fireside Chat: Confronting Inconvenient Truth

• The industry is witnessing number of market authorizations for CGTs
• Companies have deployed multiple measures to reach patients
• However, we have achieved limited success. Patients are waiting and overall business model is precarious.
• We need to go beyond current approaches to improve patient access and business viability

Sanjay Srivastava, Cell & Gene Therapy Center of Excellence Lead, Accenture

4.30pm Fireside Chat

Stephanie Heathman, Business Development Lead, Opie Jones Foundation

4.45pm Fireside Chat

Allyson Berent, Chief Scientific Officer, Foundation for Angelman Syndrome Therapeutics